T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Polaris
PII
$3.9B
| $1.64M | ﹤0.01% |
33,992
+1,336
| +4% | +$110K |
|
1552
Northwest Natural Holdings
NWN
$2.12B
| $1.62M | ﹤0.01% |
26,288
+789
| +3% | +$55.2K |
|
1553
MasTec
MTZ
$22.6B
| $1.62M | ﹤0.01% |
49,466
-4,425
| -8% | -$225K |
|
1554
Regal Rexnord
RRX
$11.5B
| $1.61M | ﹤0.01% |
25,526
+3,239
| +15% | +$254K |
|
1555
Clean Harbors
CLH
$16.7B
| $1.59M | ﹤0.01% |
31,048
+3,444
| +12% | +$252K |
|
1556
Starwood Property Trust
STWD
$6.09B
| $1.59M | ﹤0.01% |
154,869
+18,747
| +14% | +$411K |
|
1557
Arrow Electronics
ARW
$10.6B
| $1.57M | ﹤0.01% |
30,324
-3,410
| -10% | -$242K |
|
|
TBIO
1558
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.57M | ﹤0.01% |
157,064
-13,145
| -8% | -$108K |
|
1559
Liberty Media Series A
FWONA
$23.7B
| $1.56M | ﹤0.01% |
63,305
+14,359
| +29% | +$517K |
|
|
BCPC
1560
Balchem Corp
BCPC
$5.65B
| $1.55M | ﹤0.01% |
15,748
+766
| +5% | +$78.5K |
|
1561
Bank of Hawaii
BOH
$3.13B
| $1.55M | ﹤0.01% |
27,997
+290
| +1% | +$23.3K |
|
1562
Simpson Manufacturing
SSD
$7.99B
| $1.54M | ﹤0.01% |
24,886
-1,062,043
| -98% | -$82.9M |
|
1563
Travel + Leisure Co
TNL
$4.58B
| $1.53M | ﹤0.01% |
70,646
-4,750
| -6% | -$198K |
|
1564
Silicon Laboratories
SLAB
$7.3B
| $1.53M | ﹤0.01% |
17,939
+2,426
| +16% | +$241K |
|
1565
X4 Pharmaceuticals
XFOR
$425M
| $1.53M | ﹤0.01% |
+5,107
| New | +$1.45M |
|
1566
Trinity Industries
TRN
$2.3B
| $1.53M | ﹤0.01% |
95,299
-16,970
| -15% | -$340K |
|
1567
MDU Resources
MDU
$4.27B
| $1.53M | ﹤0.01% |
187,027
+18,146
| +11% | +$191K |
|
1568
Protolabs
PRLB
$2.17B
| $1.52M | ﹤0.01% |
19,990
-932
| -4% | -$86.4K |
|
1569
LiveRamp
RAMP
$2.3B
| $1.52M | ﹤0.01% |
46,211
+787
| +2% | +$29.8K |
|
1570
Columbia Sportswear
COLM
$2.88B
| $1.49M | ﹤0.01% |
21,419
+132
| +0.6% | +$11.2K |
|
|
UN
1571
DELISTED
Unilever NV New York Registry Shares
UN
| $1.48M | ﹤0.01% |
30,382
| – | – |
|
1572
Otter Tail
OTTR
$3.87B
| $1.48M | ﹤0.01% |
33,289
+265
| +0.8% | +$13.2K |
|
1573
Tucows
TCX
$140M
| $1.48M | ﹤0.01% |
30,665
-422,728
| -93% | -$23.7M |
|
1574
Darling Ingredients
DAR
$10B
| $1.48M | ﹤0.01% |
77,145
+15,881
| +26% | +$403K |
|
1575
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $1.47M | ﹤0.01% |
61,500
+29,900
| +95% | +$895K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.